Cargando…
Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)
This study identified an 80% shutdown of sleep apnoea management throughout Europe. Most services have been limited to phone-based follow-up and the management of high-priority cases. Mitigation strategies appear to be insufficiently exploited. https://bit.ly/2KWf3IY
Autores principales: | Grote, Ludger, McNicholas, Walter T., Hedner, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236823/ https://www.ncbi.nlm.nih.gov/pubmed/32366489 http://dx.doi.org/10.1183/13993003.01323-2020 |
Ejemplares similares
-
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database
por: van Zeller, Mafalda, et al.
Publicado: (2023) -
Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
por: Palm, Andreas, et al.
Publicado: (2022) -
Clinical characteristics and positive airway pressure adherence among elderly European sleep apnoea patients from the ESADA cohort
por: Lammintausta, Aino, et al.
Publicado: (2023) -
Clinical Phenotypes and Comorbidity in European Sleep Apnoea Patients
por: Saaresranta, Tarja, et al.
Publicado: (2016) -
Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea
por: Justeau, Grégoire, et al.
Publicado: (2022)